Differential regulation of CYP3A4 promoter activity by a new class of natural product derivatives binding to pregnane X receptor
Authors:
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 86 (6) , 824-835
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Sesamin: A Naturally Occurring Lignan Inhibits CYP3A4 by Antagonizing the Pregnane X Receptor ActivationEvidence-Based Complementary and Alternative Medicine, 2012
- Camptothecin Attenuates Cytochrome P450 3A4 Induction by Blocking the Activation of Human Pregnane X ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2010
- The Phytoestrogen Coumestrol Is a Naturally Occurring Antagonist of the Human Pregnane X ReceptorMolecular Endocrinology, 2008
- A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X ReceptorDrug Metabolism and Disposition, 2008
- Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding SitesMolecular Pharmacology, 2007
- The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear ReceptorMolecular Pharmacology, 2007
- Regulation and Binding of Pregnane X Receptor by Nuclear Receptor Corepressor Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT)Molecular Pharmacology, 2006
- Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase CBiochemical Pharmacology, 2005
- Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolismDrug Discovery Today, 2004
- Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-HydroxytamoxifenDrug Metabolism and Disposition, 2002